Notice of shareholders meeting convened by NCLT to be held on June 03,2026
KOPRAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kopran Ltd is convening an NCLT-directed shareholder meeting on June 3, 2026, to seek approval for a Scheme of Amalgamation where Kopran Laboratories Limited (wholly-owned subsidiary concept) will merge into Kopran Ltd. The merger will increase promoter shareholding from 44.43% to 55.33%, while public shareholders' stake will decrease from 55.57% to 44.67%. The company states the impact on public shareholders' rights and value is nil. The share exchange ratio report was prepared by Ernst & Young and Armslength Advisors, with a fairness opinion from Safforn Capital Advisors. Both BSE and NSE have issued observation letters approving the scheme. Remote e-voting runs from May 27 to June 2, 2026.
Public shareholders will see their stake diluted by 10.90 percentage points upon merger completion. While the company claims nil impact on value, the reduction in public float may affect stock liquidity. The scheme requires NCLT approval after shareholder sign-off.